This trial may be relevant to synovial sarcoma:
https://clinicaltrials.gov/ct2/show/NCT02368951
Indeed according to the following study, SYT-SSX2 upregulates FGFR2:
This trial may be relevant to synovial sarcoma:
https://clinicaltrials.gov/ct2/show/NCT02368951
Indeed according to the following study, SYT-SSX2 upregulates FGFR2: